Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/naloxone prolonged-release vs oxycodone prolonged-release in non-cancer pain with opioid-induced constipation
CTR20130159Phase 3Completed
- Sponsor
- Napp Pharmaceuticals
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone + naloxone in Musculoskeletal pain, sponsored by Napp Pharmaceuticals. Started Dec 2018; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
Musculoskeletal pain
Beyond the preview
Go deeper on CTR20130159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130159.